Logo image of ELEV

ELEVATION ONCOLOGY INC (ELEV) Stock Analyst Ratings

NASDAQ:ELEV - Nasdaq - US28623U1016 - Common Stock - Currency: USD

0.3603  +0.02 (+5.04%)

After market: 0.3603 0 (0%)

Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to ELEV. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 2.09. This target is 480.35% above the current price.
ELEV was analyzed by 14 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about ELEV.
In the previous month the buy percentage consensus was at a similar level.
ELEV was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
ELEV Historical Analyst RatingsELEV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -45 -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.360.711.022.097.35 - 96.23% 183.10% 480.35% 1,939.97%
ELEV Current Analyst RatingELEV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-03-24 Stephens & Co. Downgrade Overweight -> Equal-Weight
2025-03-21 Citizens Capital Markets Downgrade Market Outperform -> Market Perform
2025-03-21 Leerink Partners Downgrade Outperform -> Market Perform
2025-03-21 Piper Sandler Downgrade Overweight -> Neutral
2025-03-21 HC Wainwright & Co. Maintains Buy -> Buy
2025-03-10 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-03-10 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-07 Stephens & Co. Reiterate Overweight -> Overweight
2025-01-14 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-03 William Blair Initiate Outperform
2024-12-19 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-12-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-06 Stephens & Co. Reiterate Overweight -> Overweight
2024-08-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-15 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-06-28 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-05-31 Piper Sandler Initiate Overweight
2024-05-14 Stephens & Co. Initiate Overweight
2024-05-03 Wedbush Reiterate Outperform -> Outperform
2024-04-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-07 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-03-07 Wedbush Maintains Outperform -> Outperform
2024-03-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-01 JMP Securities Initiate Market Outperform
2024-02-20 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-06 Wedbush Reiterate Outperform -> Outperform
2023-09-29 HC Wainwright & Co. Initiate Buy
2023-06-05 Wedbush Maintains Outperform -> Outperform
2023-05-30 SVB Securities Upgrade Market Perform -> Outperform
2023-03-10 Wedbush Reiterate Outperform